Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 406

1.

Cotransplantation of ex vivo expanded and unexpanded cord blood units in immunodeficient mice using insulin growth factor binding protein-2-augmented mesenchymal cell cocultures.

Ong LM, Fan X, Chu PP, Gay FP, Bari S, Ang JM, Li Z, Chen J, Lim SK, Bunte RM, Hwang WY.

Biol Blood Marrow Transplant. 2012 May;18(5):674-82. doi: 10.1016/j.bbmt.2012.01.001. Epub 2012 Jan 9.

2.

Mesenchymal stromal cell supported umbilical cord blood ex vivo expansion enhances regulatory T cells and reduces graft versus host disease.

Fan X, Gay FP, Ong SY, Ang JM, Chu PP, Bari S, Lim TK, Hwang WY.

Cytotherapy. 2013 May;15(5):610-9. doi: 10.1016/j.jcyt.2012.12.007. Epub 2013 Feb 16.

PMID:
23419678
3.

Delayed engraftment of nonobese diabetic/severe combined immunodeficient mice transplanted with ex vivo-expanded human CD34(+) cord blood cells.

Guenechea G, Segovia JC, Albella B, Lamana M, Ramírez M, Regidor C, Fernández MN, Bueren JA.

Blood. 1999 Feb 1;93(3):1097-105.

4.

Human stem-progenitor cells from neonatal cord blood have greater hematopoietic expansion capacity than those from mobilized adult blood.

Tanavde VM, Malehorn MT, Lumkul R, Gao Z, Wingard J, Garrett ES, Civin CI.

Exp Hematol. 2002 Jul;30(7):816-23.

PMID:
12135681
5.

Ex vivo expanded cord blood cells provide rapid engraftment in fetal sheep but lack long-term engrafting potential.

McNiece IK, Almeida-Porada G, Shpall EJ, Zanjani E.

Exp Hematol. 2002 Jun;30(6):612-6.

PMID:
12063029
6.

Engraftment in nonobese diabetic severe combined immunodeficient mice of human CD34(+) cord blood cells after ex vivo expansion: evidence for the amplification and self-renewal of repopulating stem cells.

Piacibello W, Sanavio F, Severino A, Danè A, Gammaitoni L, Fagioli F, Perissinotto E, Cavalloni G, Kollet O, Lapidot T, Aglietta M.

Blood. 1999 Jun 1;93(11):3736-49.

7.

In vitro and in vivo evidence for the long-term multilineage (myeloid, B, NK, and T) reconstitution capacity of ex vivo expanded human CD34(+) cord blood cells.

Kobari L, Pflumio F, Giarratana M, Li X, Titeux M, Izac B, Leteurtre F, Coulombel L, Douay L.

Exp Hematol. 2000 Dec;28(12):1470-80.

PMID:
11146169
8.

Protective role of functionalized single walled carbon nanotubes enhance ex vivo expansion of hematopoietic stem and progenitor cells in human umbilical cord blood.

Bari S, Chu PP, Lim A, Fan X, Gay FP, Bunte RM, Lim TK, Li S, Chiu GN, Hwang WY.

Nanomedicine. 2013 Nov;9(8):1304-16. doi: 10.1016/j.nano.2013.05.009. Epub 2013 Jun 1.

PMID:
23732300
9.
10.

Long-term platelet production assessed in NOD/SCID mice injected with cord blood CD34+ cells, thrombopoietin-amplified in clinical grade serum-free culture.

Mattia G, Milazzo L, Vulcano F, Pascuccio M, Macioce G, Hassan HJ, Giampaolo A.

Exp Hematol. 2008 Feb;36(2):244-52. Epub 2007 Nov 26.

PMID:
18023520
11.

Comparison of Different Cytokine Conditions Reveals Resveratrol as a New Molecule for Ex Vivo Cultivation of Cord Blood-Derived Hematopoietic Stem Cells.

Heinz N, Ehrnström B, Schambach A, Schwarzer A, Modlich U, Schiedlmeier B.

Stem Cells Transl Med. 2015 Sep;4(9):1064-72. doi: 10.5966/sctm.2014-0284. Epub 2015 Jul 9.

12.

Successful short-term ex vivo expansion of NOD/SCID repopulating ability and CAFC week 6 from umbilical cord blood.

Kusadasi N, van Soest PL, Mayen AE, Koevoet JL, Ploemacher RE.

Leukemia. 2000 Nov;14(11):1944-53.

PMID:
11069030
13.

Co-culture of cord blood CD34(+) cells with human BM mesenchymal stromal cells enhances short-term engraftment of cord blood cells in NOD/SCID mice.

Fei XM, Wu YJ, Chang Z, Miao KR, Tang YH, Zhou XY, Wang LX, Pan QQ, Wang CY.

Cytotherapy. 2007;9(4):338-47.

PMID:
17573609
15.

Hematopoietic repopulating ability of CD34⁺ progenitor cells ex vivo expanded with different cytokine combinations.

Du Z, Jin H, Cai H, Yang S, Tan WS.

Artif Cells Nanomed Biotechnol. 2015;43(6):398-402. doi: 10.3109/21691401.2014.897630. Epub 2014 Mar 25.

PMID:
24665846
16.

Serum-free coculture system for ex vivo expansion of human cord blood primitive progenitors and SCID mouse-reconstituting cells using human bone marrow primary stromal cells.

Yamaguchi M, Hirayama F, Kanai M, Sato N, Fukazawa K, Yamashita K, Sawada K, Koike T, Kuwabara M, Ikeda H, Ikebuchi K.

Exp Hematol. 2001 Feb;29(2):174-82.

PMID:
11166456
17.

Ex vivo expansion of human umbilical cord hematopoietic progenitor cells using a coculture system with human telomerase catalytic subunit (hTERT)-transfected human stromal cells.

Kawano Y, Kobune M, Yamaguchi M, Nakamura K, Ito Y, Sasaki K, Takahashi S, Nakamura T, Chiba H, Sato T, Matsunaga T, Azuma H, Ikebuchi K, Ikeda H, Kato J, Niitsu Y, Hamada H.

Blood. 2003 Jan 15;101(2):532-40. Epub 2002 Sep 5.

18.

An in vivo competitive repopulation assay for various sources of human hematopoietic stem cells.

Rosler ES, Brandt JE, Chute J, Hoffman R.

Blood. 2000 Nov 15;96(10):3414-21.

19.
20.

Cord blood CD34+ cells expanded on Wharton's jelly multipotent mesenchymal stromal cells improve the hematopoietic engraftment in NOD/SCID mice.

Milazzo L, Vulcano F, Barca A, Macioce G, Paldino E, Rossi S, Ciccarelli C, Hassan HJ, Giampaolo A.

Eur J Haematol. 2014 Nov;93(5):384-91. doi: 10.1111/ejh.12363. Epub 2014 May 26.

PMID:
24797266

Supplemental Content

Support Center